Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial

Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.4, replacing the previous v3.5.3. This reflects a small software update to the site without altering the study details presented.
    Difference
    0.0%
    Check dated 2026-05-18T03:41:43.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:30:20.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:50:08.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 in the Study Documents section.
    Difference
    0.0%
    Check dated 2026-03-21T17:41:02.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a metadata update with no visible changes to core content.
    Difference
    0.0%
    Check dated 2026-03-07T12:49:15.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Revision badge updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:55:55.000Z thumbnail image

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.